| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.03B | 1.84B | 1.63B | 1.41B | 1.12B | 958.43M |
| Gross Profit | 774.84M | 691.01M | 607.77M | 515.45M | 431.36M | 334.50M |
| EBITDA | 417.71M | 357.59M | 321.59M | 276.24M | 229.58M | 204.18M |
| Net Income | 241.44M | 198.30M | 184.56M | 142.97M | 114.76M | 89.48M |
Balance Sheet | ||||||
| Total Assets | 1.73B | 1.62B | 1.44B | 1.35B | 1.28B | 1.25B |
| Cash, Cash Equivalents and Short-Term Investments | 401.46M | 350.55M | 294.90M | 302.59M | 320.05M | 407.51M |
| Total Debt | 434.46M | 366.61M | 271.76M | 313.65M | 347.38M | 331.24M |
| Total Liabilities | 781.24M | 688.54M | 552.53M | 587.94M | 589.75M | 528.68M |
| Stockholders Equity | 952.39M | 929.86M | 889.44M | 758.18M | 693.16M | 719.17M |
Cash Flow | ||||||
| Free Cash Flow | 286.88M | 222.26M | 158.40M | 121.31M | 147.14M | 160.75M |
| Operating Cash Flow | 338.68M | 268.52M | 211.20M | 166.14M | 184.39M | 202.97M |
| Investing Cash Flow | -107.23M | -119.10M | -12.00M | -96.55M | -114.27M | -18.32M |
| Financing Cash Flow | -214.86M | -119.10M | -181.45M | -81.72M | -146.88M | -89.56M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $6.76B | 12.52 | 22.37% | 1.41% | 7.40% | -14.45% | |
72 Outperform | $4.90B | 20.60 | 25.96% | ― | 14.43% | 29.86% | |
72 Outperform | $12.52B | 25.31 | 13.18% | ― | 12.61% | 11.85% | |
68 Neutral | $9.26B | 20.67 | 10.34% | ― | 14.26% | -15.49% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
50 Neutral | $2.03B | -1.56 | -37.82% | 3.38% | 3.40% | 53.13% |
On December 15, 2025, EXL repurchased 1,551,970 shares of its common stock from Orogen Echo LLC for $63,373,143, reflecting confidence in its performance and future growth. This transaction, separate from EXL’s $500 million share repurchase program, underscores the company’s commitment to returning capital to shareholders while maintaining strategic partnerships, as Orogen’s CEO Vikram Pandit continues as EXL’s Lead Independent Director.
The most recent analyst rating on (EXLS) stock is a Buy with a $45.00 price target. To see the full list of analyst forecasts on Exlservice Holdings stock, see the EXLS Stock Forecast page.